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Abstract We investigated the effect of protein disulfide iso- 
merase (PDI) on in vivo protein folding of human lysozyme 
(h-LZM) in a specially constructed yeast coexpression system. 
Coexpression with PDI increased the amounts of intracellular 
h-LZM with the native conformation, leading to an increase in 
h-LZM secretion. The results indicated that PDI is a real cata- 
lyst of protein folding in the cell. The secretion of h-LZM in- 
creased even when both active sites of PDI were disrupted, sug- 
gesting that the effect of PDI resulted from a function other than 
the formation of disulfide bonds. This is the first finding that PD! 
without isomerase activity accelerates protein folding in vivo. 
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which misfolded proteins are destined to degradation i  the cell 
[9,10]. The physiological role of these multiple function of PDI 
during protein folding in the cell remains obscure. 
As PDI promotes the in vitro folding of  various proteins, the 
mechanism of the in vivo protein folding catalyzed by PDI can 
be used to improve expression systems for foreign genes. In this 
study, we constructed a coexpression system of PDI and human 
lysozyme (h-LZM) as the substrate in a single yeast cell and we 
investigated the effect of PDI on the in vivo folding of the 
disulfide-bonded protein. We describe the potential function of 
PDI other than the formation of disulfide bonds during the in 
vivo protein folding and the use of PDI in developing more 
efficient expression systems for foreign genes. 
2. Experimental 
1. Introduction 
Protein disulfide isomerase (PDI) activity was first discov- 
ered by Anfinsen's group in rat liver microsome as a catalyst 
of reduced ribonuclease reactivation [1] and PDI catalyzes the 
formation, reduction, and isomerization of disulfide bonds in 
vitro [2]. Two sequences consisting of-Cys-Gly-His-Cys- are 
responsible for the oxidoreductase activity of PDI [3]. Glutathi- 
one is involved in PDI-mediated isulfide bond formation of 
a protein in the cell [4]. The genetic substitution of wild type 
PDI with a mutant lacking its activity leads to a delay in disul- 
fide bond formation of carboxypeptidase Y in yeast cells, sug- 
gesting that PDI assists folding of disulfide-bonded proteins in 
vivo [5]. On the other hand, PDI exhibits chaperone-like activ- 
ity in the in vitro refolding of proteins [6-8]. Furthermore, PDI 
is suggested to be involved in the quality control system, in 
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2.1. Strains and vectors 
The Saccharomyces cerevisiae haploid strain YPH499 (MATa, ura3- 
52, lvs801 "'°~', ade-lO1 °ch~, trpl-A63, his3-A200, leu2-A1) [11] was used 
as the host for integrating expression units of h-lysozyme and PDI 
genes. Plasmids pRS303, pRS304, pRS305, and pRS306 [11] were used 
lo construct integration vectors. 
22. Materials 
The h-lysozyme gene was from Takeda Chemical Industries Ltd. The 
yeast glyceraldehyde 3-phosphate dehydrogenase (GAP) promoter and 
the yeast alcohol dehydrogenase (ADH) terminator were from Torten 
K.K. Restriction enzymes, pUC119, the DNA ligation kit, the site- 
directed mutagenesis kit (Mutan-K) were obtained from Takara Shuzo. 
The GeneAmp PCR reagent kit was from Perkin-Elmer. Centriconl0 
was from Amicon. DEAE Sephacel, Con A Sepharose, and Sephacryl 
S-200 were from Pharmacia. Oligonucleotides u ed for PCR and site- 
directed mutagenesis were synthesized by an automated DNA synthe- 
sizer (380A, Applied Biosystems). Dihydrofolate reductase (DHFR) 
and rhodanese were from Sigma. Chemicals of reagent quality were 
from Sigma, Wako Pure Chemical Industries, and Naealai Tesque Inc. 
2.3. General methods 
Yeast cells were grown in YPD medium or SD medium with auxotro- 
phic requirements [12]. Yeast transformations were carried out as de- 
scribed [13]. Routine recombinant DNA manipulations were performed 
as described [14]. 
2.4. AmpliIT'cation and cloning of genes 
Polymerase chain reaction [15] was performed, using a Perkin-Elmer 
Cetus DNA Thermal Cycler, in 10 mM Tris-HCl, pH 8.3, containing 
1.5 mM MgCI2, 50 mM KCI, 0.01% gelatin, 200#M dNTPs, 2.5 units 
of AmpliTaq DNA polymerase, 2 ¢tmol each of sense and antisense 
primers, and 200 ng of yeast high-molecular weight DNA as a template. 
Amplification was performed for thirty cycles of 1 min at 95°C, 2 rain 
at 37°C, and 3 min at 72°C, followed by an incubation at 7 rain at 72°C. 
Primers for amplification of the yeast PDI (y-PDI) gene [16,17] were: 
5'-AAAACTCGAGTTATGAAGTTTTCTGCT-Y (sense) and 5'-TT- 
TTTGGATCCGTTCGTGCAGTGTGA-Y (anti-sense). Full-length 
human PDI (h-PDI) cDNA was cloned by screening a human liver 
2gtl I cDNA library (Clontech) using the oligonucleotide, 5'-TGGC- 
GTCCACCTTGGCCAACCTGATCTCGGAACCTTCTGC-3' [18], 
as a probe. 
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Fig. 1. Expression vectors of h-LZM, h-PDI, and y-PDI. HLZM, HPDI, and YPDI represent coding regions of h-LZM, h-PDI, and y-PDI, 
respectively. GAP and TER show the coding sequences ofthe yeast GAP promoter and the yeast ADH terminator, respectively. Four selective marker 
genes (HIS3, TRPI, LEU2, and URA3) are shown in each vector. Physical maps of the expression vectors of mutant h-PDI (pRS-GHPDIM-305 
and pRS-GHPDIM-306) are the same as those of wild type h-PDI (pRS-GHPDI-305 and pRS-GHPDI-306), respectively, except hat the coding 
sequence of mutant h-PDI carries the mutations in its catalytic sites. 
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2.5. Site-directed mutagenesls 
Site-directed mutagenesis, asdescribed by Kunkel [19] was used to 
introduce a mutation at the junction of the signal sequence and the 
N-terminus of mature h-PDI to generate a Nael restriction site. The 
mutagenic primer was: 5'-CGGGGGCGCCGGCGCGC-Y. Muta- 
tions in the active sites of h-PDI were introduced as described above. 
The mutagenic primers used for generating mutations in the first and 
the second active sites of h-PDI were 5'-CTTGCAGTGGCCAGAC- 
CAAGGGGCATA-Y and 5'-AGTGACCAGACCATGGG-Y, re- 
spectively. 
2.6. Construction of integration vectors.lot expression ~['h-LZM, 
h-PDI, and y-PDI 
The HindIII/XhoI fragment encoding GAP promoter and the 
BamHl/KpnI fragment encoding ADH terminator were introduced to 
the multi-cloning sites of the integration vectors: pRS303, pRS304, 
pRS305, and pRS306 [11]. The resulting plasmids were designated 
pRS303E, pRS304E, pRS305E, and pRS306E, respectively. Two inte- 
gration vectors for the expression of h-LZM, designated pRS- 
GHLZM-303 and pRS-GHLZM-304, were constructed by introducing 
an XhoI/BamHI fragment encoding h-LZM between the GAP pro- 
moter and the ADH terminator in pRS303E and pRS304E, respec- 
tively. An expression vector for y-PDI, designated pRS-GYPDI-305, 
was constructed by introducing the XhoI/BamHI fragment encoding 
y-PDI into the XhoI/BamHI site in pRS305E. Integration vectors for 
expression of h-PDI were constructed as follows. A DNA fragment 
encoding the signal sequence of human serum albumin (HSA) was 
generated by the annealing and subsequent ligation of the 
phosphorylated oligonucleotides (5"-TCGAGAATTCATGAAGTGG- 
GTTACCTTCATCTCT'Iq'GTTGTT-Y, 5'-AACAAGAACAACAA- 
AGAGATGAAGGTAACCCACTTCATGAATTC-Y, 5'-CTTGTT- 
CTCTTCTGCTTACTCTAGAGGTGTTTTCAGAAGGCCTG-Y, 
and 5'-GATCCAGGCCTTCTGAAAACACCTCTAGAGTAAGCA- 
GAAGAG-3"), and subcloned into the Xhol site of pUC119X, which 
was produced by introducing a XhoI linker into the EcoRI site of 
pUC 119. The plasmid was designated pUC 119sig. The EeoRIIBamHI 
fragment encoding h-PDI was subcloned into the EcoRI/BamHI site of 
pUC119 and a NaeI restriction site was generated at the junction be- 
tween the signal sequence and the N-terminus of mature h-PDl by 
site-directed mutagenesis a  described above. The plasmid was digested 
with NaeI and BamHI, then the mature h-PDI coding sequence was 
excised and cloned into the StulIBamHI site of pUC119sig. The result- 
ing plasmid, designated pHPDI, was digested with EcoRI, followed by 
fill-in with the Klenow fragment, and the DNA fragment containing 
h-PDI with the signal sequence of HSA was excised from the vector by 
BamHI digestion and cloned into the Xhol/BamHl site, in which thc 
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former protruding end had been filled-in with Klenow fragment, just 
downstream of the GAP promoter in pRS305E and pRS306E, respec- 
tively. These integration vectors were designated pRS-GHPDI-305 and 
pRS-GHPDI-306, respectively. Expression vectors of mutant h-PDI 
(pRS-GHPDIM-305 and pRS-GHPDIM-306) was constructed in the 
same manner as described for wild type h-PDI. The control integration 
vectors, designated pRSA305 and pRSA306, were produced by XhoI/ 
BamHI digestion, filled-in with the Klenow fragment, followed by the 
self-ligation of pRS305E and pRS306E, respectively. All of the vectors 
were linearized at unique restriction sites in selective marker genes 
(HIS4, TRP1, LEU2, and URA3) before transformation. 
2.7. Purification of recombinant h-PDI 
An yeast strain expressing recombinant wild type h-PDI (HPI) was 
grown in selective SD medium at 30°C for 48 h and further grown in 
12 liters of fresh YPD medium, of which the pH was adjusted to 7.0 
by 50 mM sodium phosphate, at30°C for 48 h. After centrifugation, 
the supernatant was applied directly on a DEAE-Sephacel column 
(5.0 × 30 cm) equilibrated with 20 mM sodium phosphate buffer (pH 
6.3) and eluted at a flow rate of 25 ml/h with a linear gradient of NaCI 
(0~1.0 M). Recombinant PDI was detected in the eluate with about 0.6 
M NaCI. The fractions containing PDI were collected, concentrated 
with a Centricon 10, applied to a Con A Sepharose column (1.5 × 15 cm) 
equilibrated with 0.5 M NaCI/20 mM Tris-HCl buffer (pH 7.4) and 
eluted with the same buffer. The flow through fractions were pooled, 
applied to a Sephacryl S-200 column (1.5 × 170 cm) equilibrated with 
0.5 M NaCI/100 mM sodium phosphate buffer (pH 7.0), and eluted at 
a flow rate of 0.1 ml/min with the same buffer. PDI was eluted at around 
120 ml. Mutant h-PDI was purified in the same manner as described 
above except hat the yeast strain secreting the mutant protein (HP2) 
was used. Protein concentrations were measured using the protein assay 
kit (Bio-Rad) with bovine T-globulin as standard. 
2.<~¢. Preparation q/crude yeast extracts 
Yeast crude cell extracts were prepared basically as described [20]. 
Stationary cultures of yeast were inoculated into 250 ml of fresh YPD 
medium and grown at 30°C to mid-logarithmic phase. The cells were 
harvested, suspended in 50 ml of buffer A (50 mM sodium phosphate, 
20 mM EDTA, 50 mM NaCI, pH 7.5), and ruptured at 9,000 psi for 
five times with a French pressure cell press (SLM Instruments Inc.). The 
resulting suspension was adjusted to pH 7.0 with 1 M Tris, then phen- 
ylmethylsulfonyl fluoride was added (2 raM), After centrifugation at
15,000 x g for 30 rain, the supernatant was concentrated with ammo- 
nium sulfate (30-85% saturation) and dialyzed against buffer B (50 mM 
sodium phosphate, 10 mM EDTA, 50 mM NaCI, pH 7.0). The dia- 
lyzate was used for assay of intracellular PDI activity. 
Table 1 
Strains used in this study 
Strain 
YPH499 
HL1 
HL2 
HLI0 
HLP1 l 
HLPl2 
HLP21 
HLP30 
HLP3 l 
HP1 
HP2 
Genotype 
MATa, ura3, lys2, ade2, trpl, his3. Icu2 
MATa, ura3. lys2, ade2, trpl, his3:: :HIS3, GAP-HLZM).  leu2 
MATa, ura3. lys2, ade2, trpl :: (TRPI.  GAP-HLZML 
his3:: (H1S3, GAP-HLZM),  leu2 
MATa. ura3, lys2, ade2, trpl :. '(TRPl. GAP-HLZM),  
his3:: ( H1S3 GAP-HLZM),  leu2.': ( LEL,~, GAP-A) 
MATa, ura3, lys2, ade2, trpl :: (TRPI,  GAP-HLZM).  
his3:. (HIS3, GAP-HLZM),  leu2.. ' LEL~, GAP-HPD1) 
MATa, ura3, lys2, ade2, trpl :: : TRP1. GAP-HLZML 
his3:: (HIS3, GAP-HLZM),  leu2.: ," LEt~, GAP-HPDIM) 
MATa, ura3. lys2, ade2, trpl :: :'TRPI. GAP-HLZM),  
his3:: (HIS3, GAP-HLZM),  leu2.: :' LEl_~. GAP-YPDI~ 
MATa, ura3 : : ( URA3, GAP-A), lys2, ade2, trpl :." : TRP1, GAP-HLZM ), 
his3:: (HIS3, GAP-HLZM),  leu2 v : LE(~. GAP-HPD1) 
MATa, ura3:: (URA3, GAP-HPDI:. Iv.s2. ac#2. trpl :: :TRP1. GAP-HLZM),  
his3:: (HIS3, GAP-HLZM),  leu2 : LEt,2. GAP-HPDI) 
~/IATa, ura3:: (URA3, GAP-HPDI:. Iv~2, ade2, trpl, his3, 
leu2.: (LEU2, GAP-HPDIj 
MATa, ura3.': ( URA3, GAP-HPDIM,,. lyC. ade2, tq~l, his3, 
leu2:: (LEU2, GAP-HPDIM) 
HLZM, HPDI, YPDI and HPDIM represent human [ysozyme, human PD1. yeast PDI and mutant human PDI, respectively. A represents he 
integration of control plasmid pRSA305 and pRSA306. 
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2.9. Assay of enzyme activity 
PDI activity was assayed by measuring the rate of reactivation of 
scrambled ribonuclease A (RNase A) [21]. Yfiiol:protein disulfide ox- 
idoreductase (TPOR) activity was assayed by the method, in which the 
enzyme-catalyzed reduction of disulfide bonds of insulin by GSH is 
linked to the reduction of GSSG to GSH, by NADPH and glutathione 
reductase [22]. The lytic activity of h-lysozyme was measured using 
Micrococcus lysodeiktieus cells as a substrate [23]. 
2.10. Assay of chaperone activity 
The effect of purified recombinant h-PDI on the reactivation of 
unfolded DHFR and the aggregation ofunfolded rhodanese was inves- 
tigated as described [24]. 
3. Results and discussion 
To elucidate the possible involvement of PDI in the step of 
protein folding in the cell, the coexpression system of PDI and 
h-LZM as a substrate was constructed using a set of yeast 
integrating plasmid vectors (YIp) with multi-cloning sites. In 
this study, h-LZM was selected as the substrate for PD1 be- 
cause it is a small and simple protein, consisting of 130 amino 
acid residues, with four disulfide bonds and because the forma- 
tion of its disulfide bonds is crucial for in vivo folding [25,26]. 
In the integration vectors, h-LZM, h-PDI, and y-PDI were 
constitutively expressed under the control of the yeast GAP 
promoter with transcriptional termination by the yeast ADH 
terminator (Fig. 1). In h-PDI expression, it should be noted that 
the signal sequence of h-PDI was substituted with that of HSA 
because h-PDI was degraded in yeast, when expressed with its 
authentic signal sequence, possibly due to a failure in its proc- 
essing. This construction actually allowed us to express func- 
tional h-PDI, while the amino-terminal residue (Asp) of native 
mature h-PDI was changed to Gly. The expression units of 
h-EZM, h-PDI, and y-PD! in the vectors were integrated by 
homologous recombination to the sites of the selective marker 
genes (ura3, trpl, his3, and leu2) on yeast chromosomes of the 
host strain (YPH499), which contain non-revertible auxotro- 
phic mutations. The strains constructed and used in this study 
are described in Table 1. 
As shown in Fig. 2A and B, h-PD|  facilitated the secretion 
of h-LZM to an extent of 128% and 122% of the control after 
24 and 48 h in culture, respectively. The effect of y-PDI on 
h-LZM secretion was greater than that of h-PDI (148% and 
157% of the control at 24 and 48 h of culture, respectively). A 
dose effect of h-PDI on the h-LZM secretion was also evident 
(Fig. 2C), in which the increase was about 43% and 53% of the 
4-- 
F ig .  2. The effect of h-PDI and y-PDI on h-LZM secretion. (A) Yeast 
strains were grown in the YPD medium [12] for 24 h at 30°C and 750 
/A of cultures were concentrated byethanol precipitation after emoving 
the cells by centrifugation. The resulting samples were resolved by 
13.5% SDS-polyacrylamide g l electrophoresis (SDS/PAGE) and the 
gel was stained with Coomassie Brilliant Blue R-250. The results of 
SDS/PAGE of typical clones are shown. Molecular weight standards 
are indicated on the left. The bands of h-LZM are denoted by an 
arrowhead. Lane 1 = YPH499; lane 2 = HLI0; lane 3 = HLPI1; lane 
4 = HLP21; lane 5 = 0.2/~g of purified h-LZM. (B) Time course of the 
secretion of h-LZM from strains. HE10 (e: control), HLP11 (o: +h- 
PDI), and HLP21 (x: +y-PDI). The amount of secreted h-LZM was 
estimated for cultures at 24 and 48 h by measuring the lyric activity of 
h-LZM. Ten independent clones were analyzed for each strain. (C) The 
dose effect of h-PDI on the secretion of h-LZM was investigated as 
described above. HLI0 (e: control). HLPll (o: +h-PDI). HLP30 (x). 
HLP31 (l: +2h-PDi). 
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Fig. 3. The effect of mutant h-PDI on h-LZM secretion. The effect of 
mutant h-PDI, lacking isomerase activity, on the secretion of h-LZM 
was investigated as described in the legend to Fig. 2. (A) Lane 
1 = YPH499: lane 2 = HL10: lane 3 = HLPI1; lane 4 = HLP12: lane 
5 = 0.2 ~tg of purified h-LZM. (B) HL10 (e: control). HLPII (~::: +h- 
PDI). HLPI2 (×: +h-PDIM). 
control at 24 and 48 h of culture, respectively. These results 
indicated that the effect was closely related to the amount of 
intracellular h-PDI. In these experiments, trains (HLI0 and 
HL30), in which control vectors lacking only the coding se- 
quences of h-PDI or y-PDI were integrated, were used as con- 
trols, showing that the effect resulted from the coexpression of
PDI and not from the rescue of auxotrophic mutations by the 
integration, There were no apparent differences in the growth 
rates among strains (data not shown), indicating that the in- 
crease in the secretion did not result from the effect of PDI on 
the cell growth. Thus, functionally expressed h- and y-PDls 
facilitate the secretion of the substrate in vivo. 
The substitution ofboth catalytic site sequences of PDI with 
-Ser-Gly-His-Cys- leads to the complete loss of isomerase activ- 
ity in vitro [3]. To determine whether the increase of intracellu- 
lar isomerase activity was responsible tor facilitating h-LZM 
secretion, the effect of mutant h-PDI on h-LZM secretion was 
examined. The mutant h-PDI accelerated the secretion of h- 
LZM to almost he same extent as wild type h-PDI (Fig. 3A 
and B). Whereas PDI is an endoplasmic reticulum (ER)-resi- 
dent protein, recombinant PDI was secreted into the culture 
medium in small amounts in our expression system, probably 
due to overflow. Thus the wild type and the mutant h-PDls 
secreted from yeast strains HP1 and HP2 respectively, were 
purified to homogeneity (Fig, 4). Purified proteins were assayed 
for the isomerase activity using scrambled RNase A and the 
TPOR activity using insulin as a substrate. We confirmed that 
the mutant h-PDI lost its activity completely (data not shown). 
Next, we focused on the intracellular changes induced by the 
coexpression of PDI. Crude cell extracts were prepared from 
the yeast strains (HL10, HLP11, HLP12, and HLP21) and the 
amounts of intracellular h-LZM with the native conformation 
were estimated by measuring the lytic activity. As shown in 
Table 2, the increase of intracellular, folded h-LZM paralleled 
that of secreted h-LZM, indicating that the effect of PDI is 
exerted in the pre-secretory pathway. Together with the obser- 
vation that the coexpression of PDI did not affected the tran- 
scriptional level of the h-LZM gene (data not shown), it was 
strongly suggested that PDI accelerates h-LZM folding in vivo. 
The effect of PDI on the increase of intracellular h-LZM was 
more remarkable than that of secreted h-LZM, possibly due to 
some limitations in the secretory steps, such as a deficiency of 
the secretory machinery. The intracellular activities of PDI 
were also measured by the scrambled RNase and TPOR assays 
(Table 2). In the former, the activity was increased 121% in the 
extracts ofHLP11 and 243% in those ofHLP21, compared with 
that of the control (HL10), respectively. In the latter, those were 
112% for HLP11 and 248% for HLP21, respectively. Supposing 
that the specific activities of mammalian PDI and y-PDI are 
1 2 
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67 
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Fig. 4. SDS/PAGE of recombinant wild type and mutant h-PDIs. 3/lg 
of purified recombinant wild type (lane 1) and mutant (lane 2) h-PDIs 
were resolved by 13.5% SDS/PAGE, respectively, followed by staining 
with Coomassie Brilliant Blue. Molecular weight standards are shown 
on the left. 
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Table 2 
Correlation between the coexpression of PDI and in vivo folding of h-LZM 
T Hayano et al./FEBS Letters 377 (1995) 505-511 
Strain Secreted h-LZM lntracellular h-LZM Intracellular PDI activity 
RNase assay TPOR assay 
HL10 l(~ 100 100 100 
HLPll 128 250 121 112 
HLP12 135 200 101 101 
HLP21 149 550 243 248 
Average values obtained from the experiments described in Figs. 2 and 3 were used for the amount of secreted h-LZM. Values for intracellular h-LZM 
were estimated as the amount of h-LZM per total proteins in the crude cell extracts. For the RNase and TPOR assays, crude cell extracts containing 
760/lg of total proteins were used. Values for intracellular h-LZM, the RNase assay, and the TPOR assay represent the mean from two independent 
experiments. In all columns, values for HL10 are set to 100%. 
similar [20], the intracellular amount of y-PD1 was estimated 
to be 7 12 fold greater than that of h-PD1. Together with the 
findings that the amount of folded h-LZM from HLP l l  and 
HLP21 increased 250% and 550%, the effect of h-PDI on intra- 
cellular h-LZM folding is greater than that of y-PDI. In this 
experiment, he complete loss of PDI activities by the mutation 
and the effect of the mutant h-PDI, namely an increase in the 
secreted h-LZM level, were also confirmed (Table 2). Thus 
mutant h-PDI lacking its isomerase activity accelerated h-LZM 
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folding to the same extent as wild type h-PDI, suggesting that 
a function of h-PDI besides oxidoreduction of proteins is re- 
sponsible for the effect. Disruption of the PDI gene in yeast 
results in a recessive lethal mutation [16,17]. However, the loss 
of PDI activity by site-specific disruption in both catalytic sites 
does not affect the viability of yeast cells [5]. This indicates that 
the essential function of PDI does not reside in its isomerase 
activity but in its unidentified activity. On the other hand, the 
loss of PDI activity leads to a delay in the folding of car- 
boxypeptidase Y [5]. In this light, our study describes a new 
finding that the mutant h-PDI, lacking isomerase activity, ac- 
celerates the in vivo folding of the disulfide-bonded protein. 
Recently it was reported that PDI exhibits chaperone-like 
activity in the refolding of some proteins [68]. Chaperone-like 
activity of purified recombinant h-PDI was investigated. In the 
DHFR assay, no significant chaperone-like activity of h-PDI 
was evident even when PDI was present at a large molar excess 
( 10-fold against DHFR at a molar ratio) (data not shown). On 
the other hand, the chaperone-like activity of recombinant h- 
PD1 was observed in the rhodanese assay (Fig. 5A). Unlike 
GroEL, addition of Mg-ATP had no effect on the PDI-medi- 
ated suppression of rhodanese aggregation (Fig. 5A). The 
mutant h-PDI also had chaperone-like activity (Fig. 5B), indi- 
cating that PDI activity is not responsible for chaperone-like 
activity. The suppression of aggregation of denatured 
rhodanese by the mutant was more efficient than that by the 
wild type h-PDI. This could be explained by its anti-chaperone 
activity [6]. Wild type h-PDI partly prevented aggregation with 
its chaperone- like activity and partly promoted aggregation 
Fig. 5. Chaperone-like activity of h-PDI. (A) The suppression of dena- 
tured rhodanese aggregation by h-PDI was investigated [24]. Bovine 
rhodanese (800/zg) was denatured in 1 ml of buffer A (6 M guanidin- 
ium-HCl. 30 mM Tris-HCl, pH 7.4, 1 mM dithiothreitol) at 25°C for 
1 h and diluted (0.46/zM final concentration) 100-fold into buffer C (30 
mM Tris-HCl, pH 7.2, 50 mM KCI) containing 0 (e), 0.23 (m), 0.46 (D), 
and 1.38/IM (z) recombinant h-PDI, and 1.38/zM bovine serum albu- 
min (,:;) as a control. The aggregation of denatured rhodanese was 
investigated by monitoring the increase in absorbanee at320 nm. The 
effect of Mg-ATP was also investigated. Ten minutes after the dilution 
of denatured rhodanese (0.46/tM) in buffer C containing 0.46/tM 
h-PDI, 1 mM ATP and 5 mM magnesium acetate at final concentration 
were added (A). Aggregation i the absence of h-PDI was set to 100%. 
(B) The effect of the mutant h-PDI on the suppression of denatured 
rhodanese aggregation was investigated. As described above, 
rhodanese was denatured and diluted in buffer C in the presence of 0.46 
~tM wild type h-PDI (o) and 0.46,uM mutant h-PDI (1). Aggregation 
in the absence of h-PDI (e) was set to 100%. 
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with its oxidation activity, of the intermolecular disulfide bonds 
of denatured and reduced rhodanese. Coupled with our finding 
that the mutant h-PDI accelerates the folding of h-LZM in 
vivo, the chaperone- like activity of PDI could be another mode 
of function, other than its isomerase activity, involved in the 
step of protein folding in the cell. 
It should be noted that recombinant h-PDI has chaperone- 
like activity in the rhodanese, but not in the DHFR assay, 
suggesting that it has substrate-specificity in its chaperone ac- 
tivity. We suggest that proteins uch as rhodanese, which are 
liable to aggregate and unable to refold spontaneously, are 
preferable substrates for PDI, whereas proteins uch as DHFR 
or RNase A, which spontaneously refold, are not. From this 
perspective, h-LZM would not be a preferable substrate, which 
would explain why the effect of PDI described here was not so 
great as that described by Robinson et al. [27], in which the 
overexpression f PDI resulted in ten-fold higher levels of se- 
cretion of human platelet derived growth factor B and a four- 
fold increase in that of acid phosphatase. To apply PDI to an 
expression system for foreign genes, the substrate specificity of 
PDI needs to be understood. In addition, the factors that regu- 
late the dissociation of the bound polypeptides from PDI re- 
main to be elucidated. Peptidyl-prolyl cis-trans isomerase 
(PPI), another folding-assisting enzyme, has been also shown 
to possess chaperone activity in the folding of carbonic anhy- 
drase [28]. Whether or not such folding-assisting enzymes 
would actually function as molecular chaperones in the cell 
remains an issue to be resolved. 
Application of PD1 to the expression of foreign genes was 
first challenged in the E. coli system, in which E. coli PDI. 
designated DsbA [29,30], was coexpressed with various anti- 
body fragments including the single Fv fragment [31]. Coexpres- 
sion did not significantly change the folding limit of the func- 
tionally folded antibody fragments. DsbA is required for the in 
vivo folding of alkaline-phosphatase, fl-lactamase, and OmpA 
[29,30]. However, its in vivo substrates might be limited to the 
resident proteins in the periplasmic space of E. co~i, because 
DsbA is smaller than eukaryotic PDI, and lacks the domain in 
PDI that is responsible for the nonspecific peptide binding 
activity [32]. Another explanation for the quite low effect of 
DsbA, is that aggregation steps in the periplasmic space, in 
which no molecular chaperone was found, would compete with 
protein folding and they would occur prior to disulfide bond 
formation [31]. In this context, our application of PDI to the 
expression system of foreign genes suggests that the ER-resi- 
dent chaperones and/or PDI itself would promote the folding 
pathway, competing for the aggregation pathway of overex- 
pressed proteins in yeast cells. Our system will be helpful for 
studying the cooperativity among PDI, PPI, and chaperones 
during protein folding in the cell and will be improved by the 
coexpression of some see genes. 
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